Acadia Healthcare Company Inc
High Yield Bond Funds Witness Inflows for Second Consecutive Week
Investor flows in high yield bond funds were positive last week, making it the second successive week of inflows.
Universal Health Services’ Behavioral Health Business in 3Q15
Universal Health Services (UHS) is expected to benefit from its leading market position in the behavioral health business in 3Q15.
Leveraged Loan Funds Witnessed Outflows: What Does It Mean?
Leveraged loan funds saw an outflow in the week ending February 3. It’s the fifth successive week in 2016. The quantum of outflows was $405.0 million last week.
How Are Fixed Income Mutual Funds Looking 2 Months into 2016?
Except for high yield and floating-rate funds, other types of fixed income mutual funds have posted positive returns year-to-date in 2016.
Analysts’ Ratings for Genesis Healthcare and Peers in February
Of the five analysts covering Genesis Healthcare in February 2018, one has given the stock a “buy” rating.
Key Risks Facing Mednax in 2017
Mednax (MD) bills payors for services provided to patients. These payors consist of government programs like Medicare and Medicaid, contracted managed care, third parties, and private pay patients.
Understanding Mednax’s Financial Position
In 3Q17, hurricanes negatively affected Mednax’s (MD) revenues by close to $2 million. According to the company, acquisitions in radiology, anesthesia, and neonatology contributed around 430 basis points to revenue growth.
A Closer Look at Mednax’s Business Strategy
Mednax (MD) has a proven track record of expertise in the administration of physician services and a methodical approach to clinical data warehousing in fields such as research, education, and quality.
The Latest Wall Street Recommendations for Mednax
Of the total 14 analysts covering Mednax (MD) in December 2017, three analysts have given the stock a “buy” or higher rating and ten have given it a “hold” rating while one analyst has given it a “sell” rating.
Hospital Industry Reacts to the Failed Healthcare Bill
On March 24, 2017, House Speaker Paul Ryan pulled back the American Health Care Act, also known as “Trumpcare,” before votes were cast.
High US Stocks Exposure Hasn’t Helped the Ivy Global Growth Fund
It has not been a good year for the Ivy Global Growth Fund – Class A (IVINX) so far, though it has seen some improvement from the previous review period.
Changes in Behavioral Health Business May Boost UHS’s Valuations
Universal Health Services’ behavioral health revenues rose by 9.7%, from $4 billion in 2014 to $4.4 billion in 2015.
A Recap of High-Yield Bonds Year-to-Date in 2016
High yield debt issuers have been wary of volatile market conditions. High-yield bonds worth $11.9 billion have been issued as of February 19, 2016.
Leveraged Loan Funds: Continued Outflows Week Ended February 10
Returns on leveraged loans fell in the week ended February 12. The S&P/LSTA US Leveraged Loan 100 Index fell 1.1% from a week ago.
How Has LifePoint Performed on a Same-Facility Basis?
Same-facility admissions for LifePoint (LPNT) fell by 4.2% to 55,000 during 4Q15. During 4Q15, its equivalent admissions fell by 1.1% to 146,000.
US Stock Indexes Fell in December amid Falling Oil Prices
Let’s see why US stock indexes fell. The three US equity indexes that we review in this December recap series fell from November 30 to December 31, 2015.
Universal Health Services’ Behavioral Health Segment Is Strong
Universal Health Services’ behavioral health segment registered 14% growth in total revenue—from $946 million in 1Q14 to $1,076.3 million in 1Q15.
Universal Health Services is expanding into the UK market
Universal Health Services entered the UK market by acquiring Cygnet Healthcare, a leading behavioral health provider, in an all-cash deal of $335.0 million.
A closer look at Universal Health Services’ acquisition activity
Since 2011, the healthcare industry has seen a surge in mergers and acquisitions (M&A) activity, especially in the outpatient medical market.